NO20072046L - Halogensubstituerte benzodiazepinderivater - Google Patents

Halogensubstituerte benzodiazepinderivater

Info

Publication number
NO20072046L
NO20072046L NO20072046A NO20072046A NO20072046L NO 20072046 L NO20072046 L NO 20072046L NO 20072046 A NO20072046 A NO 20072046A NO 20072046 A NO20072046 A NO 20072046A NO 20072046 L NO20072046 L NO 20072046L
Authority
NO
Norway
Prior art keywords
halogen
benzodiazepine derivatives
substituted benzodiazepine
substituted
triazolo
Prior art date
Application number
NO20072046A
Other languages
English (en)
Norwegian (no)
Inventor
Andrew William Thomas
Henner Knust
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35735152&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20072046(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO20072046L publication Critical patent/NO20072046L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20072046A 2004-10-20 2007-04-20 Halogensubstituerte benzodiazepinderivater NO20072046L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04105167 2004-10-20
PCT/EP2005/010907 WO2006045429A1 (en) 2004-10-20 2005-10-11 Halogen substituted benzodiazepine derivatives

Publications (1)

Publication Number Publication Date
NO20072046L true NO20072046L (no) 2007-04-26

Family

ID=35735152

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20072046A NO20072046L (no) 2004-10-20 2007-04-20 Halogensubstituerte benzodiazepinderivater

Country Status (17)

Country Link
US (1) US7507728B2 (zh)
EP (1) EP1807432A1 (zh)
JP (1) JP4751398B2 (zh)
KR (1) KR100915469B1 (zh)
CN (1) CN101084220B (zh)
AR (1) AR051333A1 (zh)
AU (1) AU2005299031B2 (zh)
BR (1) BRPI0516244A (zh)
CA (1) CA2584757C (zh)
IL (1) IL182697A (zh)
MX (1) MX2007004640A (zh)
NO (1) NO20072046L (zh)
NZ (1) NZ554556A (zh)
RU (1) RU2007114763A (zh)
TW (1) TWI304404B (zh)
WO (1) WO2006045429A1 (zh)
ZA (1) ZA200703244B (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1937688B1 (en) * 2005-10-11 2010-08-11 F. Hoffmann-La Roche AG Imidazo benzodiazepine derivatives
EP2457569A1 (en) 2010-11-05 2012-05-30 F. Hoffmann-La Roche AG Use of active pharmaceutical compounds for the treatment of central nervous system conditions
SG189248A1 (en) * 2010-11-05 2013-06-28 Hoffmann La Roche Use of active pharmaceutical compounds for the treatment of central nervous system conditions
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain
EP3083569B1 (en) 2013-12-20 2022-01-26 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
CA2990004C (en) 2015-06-19 2024-04-23 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
US20180170941A1 (en) * 2016-12-19 2018-06-21 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
US11505555B2 (en) 2016-12-19 2022-11-22 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
AR112788A1 (es) * 2017-09-07 2019-12-11 Eisai R&D Man Co Ltd Compuesto pentacíclico
EA202190076A1 (ru) 2018-06-19 2021-09-22 Эйджинбайо, Инк. Производные бензодиазепина, композиции и способы лечения когнитивных нарушений
JP7504864B2 (ja) 2019-03-05 2024-06-24 エーザイ・アール・アンド・ディー・マネジメント株式会社 五環式複素環化合物
AU2020233452A1 (en) 2019-03-05 2021-09-02 Eisai R&D Management Co., Ltd. Salt of pentacyclic compound and crystals thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL49161A (en) * 1975-08-07 1982-04-30 Sparamedica Ag Imidazo(1,5-a)(1,4)-diazepine derivatives,their manufacture and pharmaceutical compositions containing them
CA1143728A (en) 1979-10-04 1983-03-29 Max Gerecke Imidazodiazepine derivatives
CA1174673A (en) * 1981-02-27 1984-09-18 Walter Hunkeler Imidazodiazepines
CS249148B2 (en) 1984-01-19 1987-03-12 Hoffmann La Roche Method of new imidazodiazepine's derivatives production
DK174086D0 (da) * 1986-04-16 1986-04-16 Ferrosan As Nye benzodiazepinderivater samt fremgangsmaade til fremstilling af samme
US4897392A (en) * 1989-07-03 1990-01-30 Hoechst-Roussel Pharmaceuticals, Inc. 4H-indolo(1,2-d)(1,2,4)triazolo(4,3-A)(1,4)benzodiazepines
TW201311B (zh) * 1991-06-17 1993-03-01 Hoffmann La Roche
JPH078869A (ja) * 1993-06-29 1995-01-13 Mitsubishi Chem Corp 粉粒体のコーティング方法
TWI239333B (en) * 2000-11-16 2005-09-11 Hoffmann La Roche Benzodiazepine derivatives as GABA A receptor modulators
US6686352B2 (en) * 2001-05-18 2004-02-03 Hoffmann-La Roche Inc. Substituted imidazo [1,5-a] pyrimido [5,4-d] [1] benzazepine derivatives

Also Published As

Publication number Publication date
US20060084801A1 (en) 2006-04-20
BRPI0516244A (pt) 2008-08-26
JP4751398B2 (ja) 2011-08-17
IL182697A0 (en) 2007-09-20
KR100915469B1 (ko) 2009-09-03
IL182697A (en) 2012-02-29
AU2005299031B2 (en) 2011-11-10
US7507728B2 (en) 2009-03-24
WO2006045429A1 (en) 2006-05-04
RU2007114763A (ru) 2008-11-27
CN101084220B (zh) 2010-12-15
CN101084220A (zh) 2007-12-05
AR051333A1 (es) 2007-01-03
CA2584757A1 (en) 2006-05-04
NZ554556A (en) 2009-11-27
MX2007004640A (es) 2007-06-08
TW200630371A (en) 2006-09-01
CA2584757C (en) 2012-07-03
KR20070085398A (ko) 2007-08-27
ZA200703244B (en) 2008-08-27
AU2005299031A1 (en) 2006-05-04
TWI304404B (en) 2008-12-21
EP1807432A1 (en) 2007-07-18
JP2008517010A (ja) 2008-05-22

Similar Documents

Publication Publication Date Title
NO20072046L (no) Halogensubstituerte benzodiazepinderivater
ATE402707T1 (de) Imidazoä1,5aütriazoloä1,5dübenzodiazepin- derivative zur behandlung kognitiver störungen
NO20071967L (no) Imidazo-benzodiazepinderivater
MX337817B (es) Pirazolo [1,5-a] pirimidinas de utilidad como inhibidores de proteina quinasas.
MX2010004819A (es) Derivados de [1h-pirazolo[3,4-b]piridin-4-il]-fenilo o piridin-2-ilo como proteina cinasa c-theta.
NO20056030L (no) Nye pyridopyraziner og anvendelse derav som kinaseinhibitorer
DE602004007239D1 (de) 4-AMINOTHIENOÄ2,3-dÜ PYRIMIDIN -6-CARBONITRIL-DERIVATIVE ZUR VERWENDUNG ALS PDE7 INHIBITOREN
NO20063758L (no) Pyrazolo[1,5-A]pyrimidin-7-yl-amin derivater for anvendelse i behandling av proteinkinase avhengige sykdommer
ATE316077T1 (de) Pyrimidin-essigsäure derivate geeignet zur behandlung von crth2-bedingten krankheiten
MX2010006748A (es) Pirazolo[1,5-a]pirimidinas utiles como inhibidores de jak2.
WO2007040438A3 (en) Novel imidazo [4,5 -b] pyridine derivatives as inhibitors of glycogen synthase kinase 3 for use in the treatment of dementia and neurodegenerative disorders
NO20056032L (no) Nye pyridopyraziner og anvendelse derav som kinasemodulatorer
ATE428711T1 (de) Substituierte 1h-pyrroloä3,2-b, 3,2-c und 2,3- cüpyridin-2-carbonsäureamide und verwandte analoga als inhibitoren von caseinkinase-i- epsilon
MXPA05013628A (es) Pirazolo[3,4-b]piridin-6-onas como inhibidores de gsk-3.
WO2005003103A3 (en) 2, 4, 6-tri-substituted 6-membered heterocycles and their use in the treatment of neurodegenerative diseases
ATE444069T1 (de) Chinolin-derivate zur behandlung von mglur5- rezeptor-vermittelten erkrankungen
DE60108626D1 (de) Verwendung von 5-thio, sulfinyl- und sulfonylpyrazolo 3,4-b] pyridinen als cyclin-abhängige kinase-hemmer
BR0010693A (pt) Derivados azaindol para tratamento de depressão
WO2006056873A3 (en) Therapeutic pyrazolo[3,4-b] pyridines and indazoles
ATE389655T1 (de) Pyrimidinderivate
UA86873C2 (en) SUBSTITUTED ARYL 1,4-PYRAZlNE DERIVATIVES
TW200502236A (en) Novel pyrido[2,3-d]pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents
WO2009064836A3 (en) Kynurenine-aminotransferase inhibitors
TW200514779A (en) Imidazole derivatives III
ATE297926T1 (de) Hexahydropyrazino(1'2':1,6)-pyrido(3,4-b)indole 1,4-dion-derivate zur behandlung von cardiovaskulären erkrankungen und erektionsstörungen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application